COVID SMART Clinical Advisory Board

Angela Vassallo
Angela VassalloMPH, MS, CIC, FAPIC-Chief Clinical Advisor
Angela Vassallo is a nationally recognized expert in Infection Prevention and Epidemiology. She is Co-Founder and CEO of The Safe Set, which is a team of epidemiologists, doctors, and television/film producers who provide guidance in bringing productions safely back to work. She is Co-Founder and Chief Clinical Advisor of COVID SMART, the first Infection Prevention online education program for the general public.
Ravina Kullar
Ravina KullarPharmD, MPH, FIDSA
Dr. Ravina Kullar is an Infectious Diseases global expert and researcher, with nearly 15 years of research experience. She is actively leading strategies worldwide to educate the public about various infectious diseases topics, having collaborated with the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO).
Terri Rebmann
Terri RebmannPhD, RN, CIC, FAPIC
Dr. Terri Rebmann is the Associate Dean for Academic and Faculty Affairs, Director of the Institute for Biosecurity, and a Professor of Epidemiology in the Saint Louis University College for Public Health & Social Justice. She is a PhD Nurse researcher with an emphasis in infectious disease emergency preparedness. In addition, she is board certified in Infection Prevention and Epidemiology and an APIC Fellow.
Barbara Smith
Barbara SmithRN, BSN, MPA, CIC, FAPIC
Barbara A. Smith is a Nurse Epidemiologist at the Mount Sinai Morningside and Mount Sinai West campuses in New York City. She is the infection prevention consultant for Mount Sinai International, currently advising Taikang Xianlin Drum Tower Hospital in Nanjing, China. She is an independent infection prevention consultant for multiple ambulatory practices including surgical, endoscopy, and dialysis centers in the metropolitan region.
Neil Cowen
Neil CowenPhD, MBA
Neil Cowen has a background in health service management, public health and immunology with over 40 years experience, including 19 years as CEO of health organisations. Following post-doctoral studies in the USA in immunology while training students in Master’s Programs, he returned to Australia, establishing biotechnology laboratories in the private sector. He trained in Europe in the latest vaccine technologies and subsequently in Health Economics and Health Law.